- Release Date: 22/11/24 08:44
- Summary: First patient dosed in Phase 1b study into obese subjects
- Price Sensitive: No
- Download Document 246.9KB
- Forums
- ASX - By Stock
- TYP
- Ann: First patient dosed in Phase 1b study into obese subjects
TYP
tryptamine therapeutics limited
Add to My Watchlist
3.03%
!
3.4¢

Ann: First patient dosed in Phase 1b study into obese subjects
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $47.22M |
Open | High | Low | Value | Volume |
3.3¢ | 3.4¢ | 3.3¢ | $107.2K | 3.170M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 205138 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 966665 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 205138 | 0.033 |
4 | 718171 | 0.032 |
6 | 774362 | 0.031 |
10 | 859388 | 0.030 |
3 | 202280 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 966665 | 4 |
0.036 | 164300 | 2 |
0.037 | 359600 | 3 |
0.038 | 401847 | 2 |
0.039 | 723538 | 4 |
Last trade - 16.11pm 12/08/2025 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |